This inventor holds 1 USPTO granted patent. Top assignee: National Centre for Cell Science. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Hemendra Singh Panwar and Complement-System Therapeutics.
Introduction
Hemendra Singh Panwar is an inventor associated with Maharashtra, India, and the National Centre for Cell Science. His patent work concerns a chimeric protein intended for conditions involving the complement system.
Latest Patents
Panwar is named on 1 patent: “DAF-MCP Chimeric Proteins, Process to Manufacture the Same and Use of the Chimeric Protein for Treating Pathological Conditions Involving the Complement System.” The invention describes a chimeric protein, its manufacturing process, and its proposed therapeutic use.
Career Highlights
Panwar’s listed patent reflects research focused on developing a protein-based approach to pathological conditions involving the complement system. The available information identifies the National Centre for Cell Science as his affiliated organization.
Collaborations
Arvind Sahu and Payel Ghosh are identified as Panwar’s coworkers. Their names are associated with his professional context, though specific roles in the patent are not provided here.
Conclusion
Hemendra Singh Panwar’s recorded invention connects his work at the National Centre for Cell Science with research into chimeric proteins and potential treatments for complement-system-related conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile